ICD-10 Code C83.5A | Lymphoblastic (diffuse) lymphoma, in remission Symptoms, Diagnosis, Billing

Lymphoblastic (diffuse) lymphoma, in remission is a hematological malignancy characterized by the proliferation of immature lymphoid cells. This condition is clinically significant as it indicates a response to treatment, necessitating accurate documentation for ongoing care, billing, and public health reporting. The ICD-10 Code C83.5A facilitates precise coding for healthcare providers, ensuring appropriate reimbursement and tracking of treatment outcomes.

What is ICD-10 Code C83.5A for Lymphoblastic (diffuse) lymphoma, in remission?

ICD-10 Code C83.5A represents Lymphoblastic (diffuse) lymphoma, in remission, a subtype of non-Hodgkin lymphoma characterized by the presence of lymphoblasts. This code is used when a patient has achieved remission following treatment, indicating a significant reduction in disease activity. It is essential for clinical documentation and billing to reflect the patient's current status and treatment history accurately.

ICD-10 Code C83.5A – Clinical Definition and Explanation of Lymphoblastic (diffuse) lymphoma, in remission

Lymphoblastic (diffuse) lymphoma, in remission, is a type of aggressive lymphoma that primarily affects children and young adults. It arises from immature lymphoid cells and can progress rapidly if untreated. Medical attention is crucial to manage symptoms and monitor for potential relapse.

Key Clinical Features:

• Presence of lymphoblasts in the bone marrow and peripheral blood.
• Symptoms may include lymphadenopathy, fever, and weight loss.
• Higher incidence in pediatric populations, particularly males.
• Requires prompt treatment to achieve remission and prevent complications.

ICD-10 Code C83.5A for Lymphoblastic (diffuse) lymphoma, in remission – SOAP Notes & Clinical Use

ICD-10 Code C83.5A is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code C83.5A for Lymphoblastic (diffuse) lymphoma, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.5A connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This code is essential for continuity of care, supporting billing processes, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C83.5A – Lymphoblastic (diffuse) lymphoma, in remission

Management of Lymphoblastic (diffuse) lymphoma, in remission, focuses on maintaining remission and monitoring for relapse. Hospitalization may be necessary for intensive treatment and supportive care.

Antibiotic Therapy:

• Not applicable as this condition is not infectious; however, prophylactic antibiotics may be used during chemotherapy.
• Consideration for antibiotics like amoxicillin or ceftriaxone if infections arise.
• Duration of antibiotic therapy typically aligns with the duration of neutropenia or infection.

Supportive Care:

• Regular monitoring of blood counts and organ function.
• Symptom management including pain control and nutritional support.
• Psychosocial support for patients and families.

Infection Control:

• Strict hand hygiene practices to prevent infections.
• Isolation precautions during periods of neutropenia.
• Vaccination updates as per clinical guidelines.

How to Document Symptoms of Lymphoblastic (diffuse) lymphoma, in remission (ICD-10 C83.5A) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• Denies fever, night sweats, or weight loss.
• History of previous lymphadenopathy and fatigue during treatment.

Objective:

• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• Physical examination reveals no palpable lymphadenopathy.
• Complete blood count shows normal white blood cell count.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Lymphoblastic (diffuse) lymphoma, in remission (ICD-10 Code C83.5A)

Assessment:

• Diagnosis: Lymphoblastic (diffuse) lymphoma, in remission.
• ICD-10 Code: C83.5A.
• Remission status confirmed by recent laboratory results.
• No current symptoms or complications noted.

Plan:

• Continue regular follow-up appointments every 3 months.
• Monitor for signs of relapse with periodic imaging and lab tests.
• Educate patient on signs of infection and when to seek care.

Treatment & Plan Section for ICD-10 Code C83.5A – Lymphoblastic (diffuse) lymphoma, in remission

• Regular follow-up with hematology/oncology for monitoring.
• Consideration of maintenance therapy if indicated.
• Patient education on lifestyle modifications to support health.
• Psychosocial support services referral as needed.

Using ICD-10 Code C83.5A for Lymphoblastic (diffuse) lymphoma, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in the Subjective and Objective sections.
• Use C83.5A in conjunction with relevant treatment codes for comprehensive billing.
• Document any complications or comorbidities that may affect treatment.
• Align treatment plans with clinical guidelines to support justified billing.

Related ICD-10 Codes Often Used with Lymphoblastic (diffuse) lymphoma, in remission

ICD-10 Code C83.5A in Medical Billing and Insurance for Lymphoblastic (diffuse) lymphoma, in remission

ICD-10 Code C83.5A is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document the patient's remission status clearly to support claims.
• Use C83.5A in the context of treatment plans and follow-up visits.
• Ensure all relevant clinical findings are included in the medical record.

Common CPT Pairings: